recycling-expo-2018-scientifictracks

7 / 26

Page 47
Notes:
conferenceseries.com
Volume 8 International Journal of Waste Resources
ISSN: 2252-5211 Recycling Expo 2018
June 25-26, 2018
June 25-26, 2018 | Berlin, Germany
8 th World Congress and Expo on Recycling
Waste and energy management challenges of biopharmaceutical APIs manufacturing industries in
China
Jimmy Yun
University of New South Wales, Australia
In recent years, the pharmaceutical industry in China has taken tremendous steps to reinvent itself into an environmentally
responsible manufacturing industry. However, with China being a major manufacturing center for pharmaceutical active
ingredients, the amount of solid and liquid waste as well as air pollutants being generated has posed significant challenge to
conventional treatment technologies. According to publicly released statistics, China pharmaceutical industry emitted in excess
of 500 million tons of trade effluent and 200 thousand tons of COD in 2010, representing 2.5% and 3.1% of overall industrial
emission respectively. From the government perspective, learning from the experience in the past 20 years, the Ministry of
Environmental Protection, China has significantly revamped its regulation, and at the same time, is empowered with new
enforcement authority to ensure industry comply to newly imposed stringent emission and discharge stipulated limits. It is
clear that the Chinese government is determined to reverse the environmental impact caused by rapid industrialization in the
past 2 decades and return the blue sky and clear water to the people. In view of this background, this presentation will examine
the technological challenges that are faced by the biopharmaceutical active pharmaceutical ingredients (APIs) manufacturing
industries in China, firstly from the perspective of meeting environmental regulatory compliance, and secondly from the
perspective of post-compliance impacts of the trace amount of APIs emitted to our ecosystem.
Biography
Jimmy Yun is a Professor in the University of New South Wales (UNSW), School of Chemical Engineering, and a Professor in the Hebei Science and Technology
University. After a stint of early careers in research development and industries in Japan, USA, Australia and Singapore, he founded Nanomaterials Technology Pte Ltd,
Singapore and was the CEO between 2000 and 2012, providing specialized R&D services to some of the most influential global pharmaceutical and specialty chemicals
companies. These pharmaceutical companies include GSK, Schering Plough, Johnson & Johnson, Novo Nordisk and Huabei Pharmaceutical Company etc., and specialty
chemicals companies include BASF, 3M, Evoniks, Nitto Denko and Sinopec etc. The development areas, with more than 30 patents, covered advanced drug delivery
system, particle system design, advanced environmental coating and catalyst, and polymer nano-composite etc. Currently, he is actively engaged in multiple environmental
projects with the pharmaceutical industry in China.
Jimmy Yun, Int J Waste Resour 2018, Volume 8
DOI: 10.4172/2252-5211-C1-011